Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
24.12
-0.66 (-2.66%)
At close: Nov 20, 2026, 4:00 PM EST
24.59
+0.47 (1.95%)
After-hours: Nov 20, 2026, 7:57 PM EST
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $673.89 million as of November 20, 2026. It is the 11,786th most valuable company in the world and the 2,422nd biggest in the United States. Its market cap has decreased by 24.83% in one year.
Market Cap
673.89M
Enterprise Value
31.97M
1-Year Change
-24.83%
Global Rank
Country Rank
#2,422 United States
Category
ChartMarket Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $673.89M, an increase of 330.60%. That is a compound annual growth rate of 15.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 673.90M | -17.02% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 (IPO) | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BillionToOne | 4.30B |
| CareDx | 3.68B |
| Veracyte | 2.03B |
| NeoGenomics | 1.92B |
| Personalis | 1.55B |
| GeneDx Holdings | 1.36B |
| OPKO Health | 1.17B |
| Freenome | 1.04B |